BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 895 filers reported holding BAXTER INTL INC in Q1 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,489 | -66.2% | 172 | -59.2% | 0.00% | -50.0% |
| Q2 2023 | $19,223 | +12.3% | 422 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $17,113 | -39.5% | 422 | -24.0% | 0.00% | -50.0% |
| Q4 2022 | $28,285 | +23.0% | 555 | +31.5% | 0.00% | 0.0% |
| Q3 2022 | $23,000 | -14.8% | 422 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $27,000 | -38.6% | 422 | -25.4% | 0.01% | -37.5% |
| Q1 2022 | $44,000 | -24.1% | 566 | -16.5% | 0.01% | -11.1% |
| Q4 2021 | $58,000 | -46.8% | 678 | -50.0% | 0.01% | -62.5% |
| Q3 2021 | $109,000 | -34.3% | 1,356 | -34.3% | 0.02% | -40.0% |
| Q2 2021 | $166,000 | -1.8% | 2,064 | +3.3% | 0.04% | -13.0% |
| Q1 2021 | $169,000 | +3.7% | 1,998 | -1.5% | 0.05% | -8.0% |
| Q4 2020 | $163,000 | +1.2% | 2,029 | +1.6% | 0.05% | -12.3% |
| Q3 2020 | $161,000 | -6.4% | 1,998 | 0.0% | 0.06% | -17.4% |
| Q2 2020 | $172,000 | +20.3% | 1,998 | +13.6% | 0.07% | +6.2% |
| Q1 2020 | $143,000 | -13.3% | 1,759 | -10.8% | 0.06% | +14.0% |
| Q4 2019 | $165,000 | -18.3% | 1,972 | -14.6% | 0.06% | -3.4% |
| Q3 2019 | $202,000 | +117.2% | 2,310 | +104.4% | 0.06% | +103.4% |
| Q2 2019 | $93,000 | -17.0% | 1,130 | -18.1% | 0.03% | -17.1% |
| Q1 2019 | $112,000 | +23.1% | 1,380 | 0.0% | 0.04% | +9.4% |
| Q4 2018 | $91,000 | -14.2% | 1,380 | 0.0% | 0.03% | -5.9% |
| Q3 2018 | $106,000 | +3.9% | 1,380 | 0.0% | 0.03% | -34.6% |
| Q2 2018 | $102,000 | +13.3% | 1,380 | 0.0% | 0.05% | +6.1% |
| Q1 2018 | $90,000 | +4.7% | 1,380 | +3.6% | 0.05% | +2.1% |
| Q4 2017 | $86,000 | +6.2% | 1,332 | +3.7% | 0.05% | 0.0% |
| Q3 2017 | $81,000 | +3.8% | 1,285 | 0.0% | 0.05% | -2.0% |
| Q2 2017 | $78,000 | +16.4% | 1,285 | 0.0% | 0.05% | +22.5% |
| Q1 2017 | $67,000 | +17.5% | 1,285 | 0.0% | 0.04% | +11.1% |
| Q4 2016 | $57,000 | +16.3% | 1,285 | +24.2% | 0.04% | +9.1% |
| Q3 2016 | $49,000 | +4.3% | 1,035 | 0.0% | 0.03% | -2.9% |
| Q2 2016 | $47,000 | +9.3% | 1,035 | 0.0% | 0.03% | +3.0% |
| Q1 2016 | $43,000 | +10.3% | 1,035 | 0.0% | 0.03% | +13.8% |
| Q4 2015 | $39,000 | -18.8% | 1,035 | -29.2% | 0.03% | -23.7% |
| Q3 2015 | $48,000 | -58.6% | 1,461 | -12.1% | 0.04% | -54.2% |
| Q2 2015 | $116,000 | +0.9% | 1,662 | -0.8% | 0.08% | +3.8% |
| Q1 2015 | $115,000 | -6.5% | 1,675 | -0.5% | 0.08% | -11.1% |
| Q4 2014 | $123,000 | +3.4% | 1,684 | +1.3% | 0.09% | -13.5% |
| Q3 2014 | $119,000 | +6.2% | 1,663 | +7.2% | 0.10% | +4.0% |
| Q2 2014 | $112,000 | +38.3% | 1,552 | +41.0% | 0.10% | +13.6% |
| Q1 2014 | $81,000 | +5.2% | 1,101 | 0.0% | 0.09% | +104.7% |
| Q4 2013 | $77,000 | +6.9% | 1,101 | 0.0% | 0.04% | -2.3% |
| Q3 2013 | $72,000 | -15.3% | 1,101 | -10.8% | 0.04% | -30.2% |
| Q2 2013 | $85,000 | – | 1,234 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |